Formycon Logo

Formycon

🇩🇪
FYB
DE000A1EWVY8

Formycon AG is a biopharmaceutical company headquartered in Germany, specializing in the development and manufacturing of high-quality biosimilars. The company focuses on complex biopharmaceuticals within the therapeutic areas of ophthalmology, immunology, and oncology, aiming to provide patients with access to affordable and effective medications. Formycon is driving the development of promising biosimilar candidates.

Next Quarterly Earnings

Thursday, November 12, 2026
CW 46
Pre-Market
In 77 days
Confirmed by the company

Date confirmed from the company's own financial calendar.

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 15, 2026

Stock Price

Frequently asked questions

When will Formycon report its next quarterly earnings?

Formycon is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Formycon last report quarterly earnings?

Formycon last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -0.83 EUR.

How do I add the Formycon earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-€0.08
Actual:
Q2 2026
Missed
Estimate:-€0.14
Actual:-€0.83
Difference:-€0.69
Q1 2026
Met
Estimate:-€0.59
Actual:-€0.59
Difference:+€0.00
Price reaction (1 day):-4.0 %
Price reaction (7 days):-6.2 %
Q3 2025
Estimate:
Actual:
Price reaction (1 day):+0.7 %
Price reaction (7 days):+8.6 %

Company Information

Name
Formycon
Ticker Symbol
FYB
ISIN
DE000A1EWVY8
Country
🇩🇪
Germany
Sector
More Financial Information